Delivery Order SPE2DB24D1104-SPE2DB25FYAF0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,693.94 to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules, unit dose, in quantities of six. This contract, which was competitively awarded with no set-aside designation, has a completion date of August 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order employs firm fixed price pricing and represents a continuation of the agency's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of Aprepitant 80 mg capsules under a firm fixed-price contract with a ceiling value of $1,183.49. This delivery order, designated as a non-set-aside award, falls under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The funding agency is the DLA...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV)...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,224.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Aprepitant 130mg/18ml (a chemotherapy-related nausea and vomiting preventative medication). This non-set-aside delivery order is expected to reach completion by September 8, 2025, with fulfillment taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency Troop Support Medical awarded a $693.24 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 40 mg Aprepitant capsules. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between July 18-19, 2023. Amerisourcebergen will supply the pharmaceutical products to the Defense Logistics Agency under this small dollar, short-term order to support the Agency's medical material needs. No major subcontractors...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $98,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to supply 4561439954 APREPITANT 40 MG CAPSULES. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 8-10, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for nausea...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYAF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The IDC serves as a global prime vendor contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs. Aprepitant, a chemotherapy-induced nausea and vomiting prevention medication, represents one of the specialized pharmaceutical commodities delivered through this contract vehicle to support Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 4/23/25 |